HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

MED

Medifast, Inc. (NYSE)

Consumer Cyclical — Personal Services

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans consisting of 5 & 1 Plan and 5 & 1 ACTIVE Plan, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss without the stress of figuring out what to eat. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.

None 1 analysts
$11.03
+$0.42 (+3.96%)
Target: $12.00 (8.8%)
Sign in to add MED to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$122.64M
P/E Ratio (TTM)-
Forward P/E-18.38
EPS (TTM)$-1.82
Dividend Yield-
Profit Margin-5.79%
Revenue Growth-34.30%
ROE-9.80%
Debt/Equity8.15
Recommendation None
Analyst Target$12.00
Analysts1
Indexes NYSE

Technical Indicators

RSI (14)31.8
Beta0.66
SMA 20-
SMA 40-
52-Week High$15.46
52-Week Low$9.22
50-Day Avg$11.79
200-Day Avg$11.59
Avg Volume233.0K
Volume179.6K

Performance Analysis

BEARISH

MED is flashing more cautionary signals — investors should monitor closely.

~ Trading at 29% of its 52-week range.
~ RSI at 31.8 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- Revenue declined 34.3% year-over-year.
- Operating at a loss with -5.8% margin.
~ Wall Street consensus is "none" from 1 analysts.
+ Average analyst target of $12.00 implies 8.8% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:19 UTC

Back to Screener Export Report